Oxford Nanopore Technologies Ltd (ONT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has a cash flow conversion efficiency ratio of -0.093x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-39.40 Million ≈ $-4.79K USD) by net assets (GBX424.10 Million ≈ $51.60K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Oxford Nanopore Technologies Ltd stock valuation for the company's overall valuation and market capitalisation.
Oxford Nanopore Technologies Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Oxford Nanopore Technologies Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Oxford Nanopore Technologies Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their cash flow conversion efficiency. See Oxford Nanopore Technologies Ltd (ONT) cash flow to debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
A Dong Paint JSC
VN:ADP
|
N/A |
|
CKH Food & Health Limited
KQ:900120
|
0.073x |
|
Allied Industrial Ltd
TWO:4702
|
-0.006x |
|
Marwynn Holdings, Inc. Common stock
NASDAQ:MWYN
|
-0.172x |
|
Resverlogix Corp.
TO:RVX
|
0.010x |
|
Rossell India Limited
NSE:ROSSELLIND
|
-0.043x |
|
Magna Terra Minerals Inc
V:MTT
|
0.179x |
|
Bankers Investment Trust
LSE:BNKR
|
0.029x |
Annual Cash Flow Conversion Efficiency for Oxford Nanopore Technologies Ltd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Oxford Nanopore Technologies Ltd from 2012 to 2025. View today's stock price for Oxford Nanopore Technologies Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX463.30 Million ≈ $56.37K |
GBX-62.80 Million ≈ $-7.64K |
-0.136x | +27.67% |
| 2024-12-31 | GBX586.34 Million ≈ $71.34K |
GBX-109.89 Million ≈ $-13.37K |
-0.187x | +12.12% |
| 2023-12-31 | GBX643.85 Million ≈ $78.34K |
GBX-137.30 Million ≈ $-16.71K |
-0.213x | -199.47% |
| 2022-12-31 | GBX693.56 Million ≈ $84.39K |
GBX-49.39 Million ≈ $-6.01K |
-0.071x | +6.87% |
| 2021-12-31 | GBX703.98 Million ≈ $85.65K |
GBX-53.83 Million ≈ $-6.55K |
-0.076x | +77.72% |
| 2020-12-31 | GBX185.93 Million ≈ $22.62K |
GBX-63.81 Million ≈ $-7.76K |
-0.343x | +22.79% |
| 2019-12-31 | GBX109.53 Million ≈ $13.33K |
GBX-48.68 Million ≈ $-5.92K |
-0.444x | -14.41% |
| 2018-12-31 | GBX142.89 Million ≈ $17.39K |
GBX-55.51 Million ≈ $-6.75K |
-0.388x | +45.20% |
| 2017-12-31 | GBX93.58 Million ≈ $11.39K |
GBX-66.34 Million ≈ $-8.07K |
-0.709x | -101.08% |
| 2016-12-31 | GBX145.24 Million ≈ $17.67K |
GBX-51.21 Million ≈ $-6.23K |
-0.353x | -6.91% |
| 2015-12-31 | GBX100.48 Million ≈ $12.23K |
GBX-33.14 Million ≈ $-4.03K |
-0.330x | +35.73% |
| 2014-12-31 | GBX66.02 Million ≈ $8.03K |
GBX-33.88 Million ≈ $-4.12K |
-0.513x | -45.03% |
| 2013-12-31 | GBX65.77 Million ≈ $8.00K |
GBX-23.27 Million ≈ $-2.83K |
-0.354x | +16.95% |
| 2012-12-31 | GBX49.94 Million ≈ $6.08K |
GBX-21.27 Million ≈ $-2.59K |
-0.426x | -- |
About Oxford Nanopore Technologies Ltd
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more